EQRx has an unprecedented opportunity to fundamentally change the approach to drug development and delivery that is purpose-built and integrates innovative scientific and technological advancements for the benefit of people and society.


Melanie Nallicheri is a healthcare and life sciences executive with nearly three decades of experience. Melanie served as Chief Business Officer and Head, Biopharma for Foundation Medicine; Senior Vice President, Corporate Strategy and Business Development, McKesson Distribution Solutions and McKesson Data & Analytics; and Senior Vice President, Corporate Development at Geron Corporation. She holds an MBA with honors from Columbia Business School, and an M.S. in Business and Economics from WHU Otto Beisheim School of Corporate Management.

View All